It’s a pretty universal opinion that mosquitoes are a pest of monumental proportions that serve little function globally, save to spread disease. However, investigators at the Weizmann Institute of Science’s neurobiology department are looking to put the little bloodsuckers to good use. The innovative research team took a light-sensitive protein derived from mosquitos and used it to devise an improved method for investigating the messages that are passed from neuron to neuron in the brains of mice. Findings from the new study—published recently in Neuron through an article titled, “Efficient optogenetic silencing of neurotransmitter release with a mosquito rhodopsin”—could potentially help scientists solve age-old cerebral mysteries that could pave the way for new and improved therapies to treat neurological and psychiatric conditions.

The Weizmann researchers utilized optogenetic methods that allowed them to “reverse engineer” the activity of specific brain circuits in order to better understand their function. Optogenetics uses proteins known as rhodopsins to control the activity of neurons in the mouse brain. Rhodopsins are light-sensing proteins—they are most known for their role in organs like the retina rather than in the dark inner reaches of the body. But the rhodopsins in the brains of the engineered mice enabled the team to control the activity of specific neurons when a minuscule beam of light was directed into the mouse’s brain. The scientists were especially interested in communication between neurons: What signals are getting passed through the synapses, those gaps over which the brain’s signals move?

“We can detect the presence of the various neurotransmitters, but different neurons ‘read’ those neurotransmitters differently,” explained senior study investigator Ofer Yizhar, PhD, professor and principal investigator at the Weizmann Institute of Science. “Optogenetics enables us to not only see the ‘ink,’ but really to decipher the ‘message.’”

While optogenetic methods have produced a number of breakthrough results in labs around the world in recent years, they can be a bit finicky. In particular, the rhodopsins used for optogenetic studies tend to be imperfect when it comes to controlling the activity of synapses, the tiny junctions between neurons.

The researchers felt they could create a better version of the rhodopsins than those currently available. “We decided to look around and see what natural solutions exist out there,” Yizhar noted. And nature, it turns out, contains a multitude of variations on the rhodopsin molecule—not only in animal eyes but also fish, insects, and even mammals carry them in various body parts; some possibly for regulating their circadian cycles, others for purposes as yet unknown. Thus, the team started out with a long list of potential rhodopsin proteins, and their first job involved assessing which ones were most likely to fill their experimental requirements, which primarily included light-gated proteins that can modulate synaptic activity. Eventually, the researchers sorted their list down to two—one taken from a pufferfish and one from a mosquito.

It was the mosquito rhodopsin that turned out to be the most suitable. To evaluate the efficacy of the new mosquito-derived tool, the researchers tested their method against a drug that is known to reduce the strength of the communication between neurons in the brain. They found that the interference was just as effective and much more stable with the mosquito rhodopsin.

“We showed that a targeting-enhanced mosquito homolog of the vertebrate encephalopsin (eOPN3) could effectively suppress synaptic transmission through the Gi/o signaling pathway,” the authors wrote. “Brief illumination of presynaptic terminals expressing eOPN3 triggers a lasting suppression of synaptic output that recovers spontaneously within minutes in vitro and in vivo. In freely moving mice, eOPN3-mediated suppression of dopaminergic nigrostriatal afferents induces a reversible ipsiversive rotational bias.”

Unlike a conventional drug that affects numerous parts of the brain and is hard to control, the researchers found that since only neurons that produce the mosquito sensor are affected by the light, the modulatory effect on the brain’s synapses can be precisely controlled in both space and time—just by switching the light on or off in specific brain regions. They then validated the utility of the new tool by using it to block the release of the neurotransmitter dopamine on one side of the brain only: Illuminating the hemisphere expressing the mosquito rhodopsin with green light led to a one-sided bias in the behavior of these mice. In other words, they had created a tool that was precise, selective, and controllable.

“One of the major advantages of the mosquito rhodopsin is that it’s bistable—that is, it does not need refreshing—and it is potentially very specific so that we can control just the precise synapses in which we are interested,” Yizhar concluded. “This is a very exciting technology since it will allow us to discover the roles of specific pathways in the brain in a way that was not possible before. We think this mosquito protein could open the way to developing a whole family of new optogenetic tools for use in neuroscience research.”